• Profile
Close

10‐Day and 14‐day high‐dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis

Helicobacter Aug 02, 2021

Zou PY, Hu J, Zhao JT, et al. - Researchers conducted a retrospective study examining if eradication rates for Helicobacter pylori differ by high-dose dual therapy (HDDT) with different regimens. The efficacy and safety of HDDT 10-day vs 14-day were compared and the factors that might impact the eradication rates were investigated. Propensity score matching (PSM) was done to retrieve two comparable treatment groups. Based on the therapy received, division of patients was done into two groups: 10-day HDDT and 14-day HDDT (20 mg esomeprazole and 750 mg amoxicillin, administered four times daily). Outcomes revealed a higher H. pylori eradication rate in correlation with the 14-day HDDT vs the 10-day HDDT.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay